Gulf International Bank UK Ltd Has $6.89 Million Holdings in Zoetis Inc. (NYSE:ZTS)

Gulf International Bank UK Ltd lowered its stake in shares of Zoetis Inc. (NYSE:ZTS) by 4.5% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 35,283 shares of the company’s stock after selling 1,672 shares during the period. Gulf International Bank UK Ltd’s holdings in Zoetis were worth $6,893,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Whittier Trust Co. raised its holdings in shares of Zoetis by 3.2% in the first quarter. Whittier Trust Co. now owns 10,810 shares of the company’s stock valued at $1,829,000 after purchasing an additional 332 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Zoetis by 8.0% in the 1st quarter. Whittier Trust Co. of Nevada Inc. now owns 2,792 shares of the company’s stock worth $472,000 after buying an additional 208 shares during the last quarter. Central Pacific Bank Trust Division bought a new position in shares of Zoetis in the first quarter valued at approximately $509,000. Proficio Capital Partners LLC increased its position in shares of Zoetis by 6.5% during the first quarter. Proficio Capital Partners LLC now owns 2,761 shares of the company’s stock valued at $467,000 after acquiring an additional 169 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S lifted its holdings in Zoetis by 58.6% during the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 41,931 shares of the company’s stock worth $7,095,000 after acquiring an additional 15,491 shares during the period. 92.80% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Piper Sandler increased their price objective on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, August 14th. BTIG Research increased their price objective on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, August 12th. Argus raised shares of Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Stifel Nicolaus boosted their price objective on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. Finally, JPMorgan Chase & Co. raised their price target on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Ten research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Zoetis has an average rating of “Buy” and a consensus price target of $221.44.

Zoetis Trading Down 3.7 %

Shares of ZTS stock opened at $175.18 on Tuesday. The business has a 50-day moving average price of $188.84 and a two-hundred day moving average price of $179.03. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $201.92. The company has a quick ratio of 2.09, a current ratio of 3.45 and a debt-to-equity ratio of 1.32. The firm has a market cap of $79.37 billion, a P/E ratio of 34.28, a price-to-earnings-growth ratio of 2.82 and a beta of 0.90.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.07. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. The business had revenue of $2.36 billion for the quarter, compared to analyst estimates of $2.31 billion. During the same period last year, the company earned $1.41 EPS. Zoetis’s revenue for the quarter was up 8.3% compared to the same quarter last year. Equities analysts anticipate that Zoetis Inc. will post 5.83 EPS for the current fiscal year.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st will be given a $0.432 dividend. This represents a $1.73 dividend on an annualized basis and a dividend yield of 0.99%. The ex-dividend date is Thursday, October 31st. Zoetis’s payout ratio is 33.86%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.